assessing risk in hormone receptor-positive/her2-negative early breast cancer: how to approach ch...
Published 3 weeks ago • 5 plays • Length 31:59Download video MP4
Download video MP3
Similar videos
-
28:25
managing the borderline-risk patient with hormone receptor-positive/her2-negative early breast ca...
-
30:49
conceptualizing guidelines to manage patients with hr–positive, her2-negative early breast cancer
-
1:00
defining optimal therapy in high-risk early breast cancer #shorts
-
5:32
medscapetv • going the distance with metastatic breast cancer - episode 1: the journey begins
-
0:50
hormonal positive breast cancer: detection, treatment & risk assessment
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
0:17
unlocking immunotherapy for breast cancer
-
57:18
breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
4:18
lhrh analogue goserelin helps preserve fertility in hormone receptor-negative breast cancer
-
58:39
high-risk patient breast cancer case panel discussion | 2022 best of breast conference
-
1:38
genomic assays for chemotherapy decisions in er-positive/her2-negative breast cancer
-
2:03:13
traco 2018 - breast cancer and epidemiology
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
57:03
ask the expert: early-stage hormone receptor-positive, her2-positive & triple-positive breast cancer
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
57:41
breast cancer management in north carolina: updates for 2021 - y. abdou - 20210623
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer